|
Klaich, G M; Kanter, P M (1995) Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigen. Anticancer Drugs 6:45-52
|
|
Verstovsek, S; Eppolito, C; Ujhazy, P et al. (1995) Murine splenic macrophage tumoricidal activation by cytokines. Exp Hematol 23:519-28
|
|
Ujhazy, P; Maccubbin, D; Eppolito, C et al. (1994) TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells. Lymphokine Cytokine Res 13:99-106
|
|
Klaich, G M; Kanter, P M (1994) Induction of dog IL-1 by free and liposomal encapsulated doxorubicin. Anticancer Drugs 5:355-60
|
|
Ujhazy, P; Klobusicka, M; Babusikova, O et al. (1994) Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin. Int J Cancer 59:83-93
|
|
Kanter, P M; Klaich, G; Bullard, G A et al. (1994) Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99) given intraperitoneally to dogs. In Vivo 8:975-82
|
|
Kanter, P M; Bullard, G A; King, J M (1994) Preclinical toxicologic evaluation of DENSPM (N1,N11-diethylnorspermine) in rats and dogs. Anticancer Drugs 5:448-56
|
|
Kanter, P M; Klaich, G M; Bullard, G A et al. (1994) Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs. Anticancer Drugs 5:579-90
|
|
Ho, R L; Maccubbin, D; Zaleskis, G et al. (1993) Development of a safe and effective adriamycin plus interleukin 2 therapy against both adriamycin-sensitive and -resistant lymphomas. Oncol Res 5:373-81
|
|
Verstovsek, S; Maccubbin, D L; Ehrke, M J et al. (1993) Polymyxin B-mediated lysis of tumor cells. Int Arch Allergy Immunol 100:47-52
|
Showing the most recent 10 out of 149 publications
